Data Foundry

Drug recalls 2019

Cardizem CD — Class III drug recall D-0488-2019

Terminated recall by Valeant Pharmaceuticals North America LLC, reported 2019-02-20, distributed nationwide. Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount

Recall numberD-0488-2019
Product typeDrug
ClassificationClass III
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmValeant Pharmaceuticals North America LLC, Bridgewater, NJ, United States
Recall initiated2019-01-30
Classified2019-02-14
Reported by FDA2019-02-20
Terminated2020-07-08
DistributedNationwide (US)
Quantity206 bottles
Reason classesspecification failure
NDC00187-0795, 00187-0795-30, 00187-0795-42, 00187-0795-49, 00187-0796, 00187-0796-30, 00187-0796-42, 00187-0796-49, 00187-0796-50, 00187-0797, 00187-0797-30, 00187-0797-42, 00187-0797-49, 00187-0798, 00187-0798-30, 00187-0798-42, 00187-0799, 00187-0799-42
Expiration dates2020-08

Product

Cardizem CD (diltiazem HCl) capsules, 180 mg, packaged in a) 30-count bottles (NDC 0187-0796-30); and b) 90-count bottles (NDC 0187-0796-42), Rx Only, Manufactured for: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807 USA; By: Valeant Pharmaceuticals International, Inc., Steinbach, MB R5G 1Z7, Canada.

Reason for recall

Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0488-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.